Filing Details

Accession Number:
0001237899-21-000017
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-08-24 16:04:45
Reporting Period:
2021-08-20
Accepted Time:
2021-08-24 16:04:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
872589 Regeneron Pharmaceuticals Inc. REGN Pharmaceutical Preparations (2834) 133444607
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1697422 R. Christopher Fenimore 777 Old Saw Mill River Road
Tarrytown NY 10591
Svp Controller No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-08-20 13,500 $179.13 32,520 No 4 M Direct
Common Stock Disposition 2021-08-23 4,576 $655.00 27,944 No 4 S Direct
Common Stock Disposition 2021-08-23 9 $659.33 27,935 No 4 S Direct
Common Stock Disposition 2021-08-23 23 $660.33 27,912 No 4 S Direct
Common Stock Disposition 2021-08-23 88 $661.89 27,824 No 4 S Direct
Common Stock Disposition 2021-08-23 1 $662.78 27,823 No 4 S Direct
Common Stock Disposition 2021-08-23 70 $663.05 27,753 No 4 S Direct
Common Stock Disposition 2021-08-23 14 $665.21 27,739 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2021-08-20 13,500 $0.00 13,500 $179.13
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2022-12-14 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 2,082 Indirect 2021 GRAT
Common Stock 1,459 Indirect By 401(k) Plan
Common Stock 1,897 Indirect By Trust
Common Stock 1,861 Indirect by 2018 GRAT
Common Stock 25 Indirect by Trust for Daugh
Common Stock 25 Indirect by Trust for Son
Footnotes
  1. Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
  2. Represents volume-weighted average price of sales of 9 shares of Company stock on August 23, 2021 at prices ranging from $659.28 to $659.45. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 23, 2021 at each separate price.
  3. Represents volume-weighted average price of sales of 23 shares of Company stock on August 23, 2021 at prices ranging from $660.09 to $660.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 23, 2021 at each separate price.
  4. Represents volume-weighted average price of sales of 88 shares of Company stock on August 23, 2021 at prices ranging from $661.47 to $661.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 23, 2021 at each separate price.
  5. Represents volume-weighted average price of sales of 70 shares of Company stock on August 23, 2021 at prices ranging from $663.00 to $663.13. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 23, 2021 at each separate price.
  6. These shares are held in a trust for the benefit of the reporting person's spouse. The reporting person and the reporting person's spouse are trustees of the trust.
  7. The stock option award vests in four equal annual installments, commencing one year after the date of grant.